Schonfeld Strategic Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,600
| Closed | -$26.6K | – | 2763 |
|
|
2022
Q4 | $26.6K | Sell |
26,600
-8,800
| -25% | -$8.79K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $64K | Sell |
35,400
-29,000
| -45% | -$52.4K | ﹤0.01% | 2551 |
|
|
2022
Q2 | $187K | Sell |
64,400
-10,000
| -13% | -$29K | ﹤0.01% | 1853 |
|
|
2022
Q1 | $205K | Buy |
74,400
+43,200
| +138% | +$119K | ﹤0.01% | 1879 |
|
|
2021
Q4 | $145K | Sell |
31,200
-210,561
| -87% | -$979K | ﹤0.01% | 1752 |
|
|
2021
Q3 | $2.06M | Buy |
+241,761
| New | +$2.06M | 0.02% | 644 |
|